Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-01-17 @ 12:56 AM
Study NCT ID:
NCT01647516
Status:
COMPLETED
Last Update Posted:
2021-05-19
First Post:
2012-07-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Ozanimod in Ulcerative Colitis
Sponsor:
Celgene
Organization:
Study Overview
Official Title:
A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo Controlled Parallel-Group Study to Evaluate the Clinical Efficacy and Safety of Induction Therapy With RPC1063 in Patients With Moderately to Severely Active Ulcerative Colitis
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Touchstone
Brief Summary:
The purpose of this study is to determine whether RPC1063 is effective in the treatment of ulcerative colitis (UC).
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: